These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16669960)

  • 21. Effects of Anti-Cytokine Antibodies on Gut Barrier Function.
    Liu F; Lee SA; Riordan SM; Zhang L; Zhu L
    Mediators Inflamm; 2019; 2019():7028253. PubMed ID: 31780866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microbiota dysbiosis and barrier dysfunction in inflammatory bowel disease and colorectal cancers: exploring a common ground hypothesis.
    Yu LC
    J Biomed Sci; 2018 Nov; 25(1):79. PubMed ID: 30413188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Clinical Importance of
    Liu F; Ma R; Wang Y; Zhang L
    Front Cell Infect Microbiol; 2018; 8():243. PubMed ID: 30087857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinoptilolite in Dextran Sulphate Sodium-Induced Murine Colitis: Efficacy and Safety of a Microparticulate Preparation.
    Nizet S; Muñoz E; Fiebich BL; Abuja PM; Kashofer K; Zatloukal K; Tangermann S; Kenner L; Tschegg C; Nagl D; Scheichl L; Meisslitzer-Ruppitsch C; Freissmuth M; Berger T
    Inflamm Bowel Dis; 2017 Dec; 24(1):54-66. PubMed ID: 29272495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mend Your Fences: The Epithelial Barrier and its Relationship With Mucosal Immunity in Inflammatory Bowel Disease.
    Martini E; Krug SM; Siegmund B; Neurath MF; Becker C
    Cell Mol Gastroenterol Hepatol; 2017 Jul; 4(1):33-46. PubMed ID: 28560287
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nod2: A Critical Regulator of Ileal Microbiota and Crohn's Disease.
    Sidiq T; Yoshihama S; Downs I; Kobayashi KS
    Front Immunol; 2016; 7():367. PubMed ID: 27703457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The serine protease-mediated increase in intestinal epithelial barrier function is dependent on occludin and requires an intact tight junction.
    Ronaghan NJ; Shang J; Iablokov V; Zaheer R; Colarusso P; Dion S; Désilets A; Leduc R; Turner JR; MacNaughton WK
    Am J Physiol Gastrointest Liver Physiol; 2016 Sep; 311(3):G466-79. PubMed ID: 27492333
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The intestinal microbiome, barrier function, and immune system in inflammatory bowel disease: a tripartite pathophysiological circuit with implications for new therapeutic directions.
    Vindigni SM; Zisman TL; Suskind DL; Damman CJ
    Therap Adv Gastroenterol; 2016 Jul; 9(4):606-25. PubMed ID: 27366227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Host-microbiome interaction in Crohn's disease: A familiar or familial issue?
    Michielan A; D'Incà R
    World J Gastrointest Pathophysiol; 2015 Nov; 6(4):159-68. PubMed ID: 26600974
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intestinal Permeability in Inflammatory Bowel Disease: Pathogenesis, Clinical Evaluation, and Therapy of Leaky Gut.
    Michielan A; D'Incà R
    Mediators Inflamm; 2015; 2015():628157. PubMed ID: 26582965
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic and Prognostic Microbial Biomarkers in Inflammatory Bowel Diseases.
    Dubinsky M; Braun J
    Gastroenterology; 2015 Oct; 149(5):1265-1274.e3. PubMed ID: 26284597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Attenuation of Colitis by Serum-Derived Bovine Immunoglobulin/Protein Isolate in a Defined Microbiota Mouse Model.
    Henderson AL; Brand MW; Darling RJ; Maas KJ; Detzel CJ; Hostetter J; Wannemuehler MJ; Weaver EM
    Dig Dis Sci; 2015 Nov; 60(11):3293-303. PubMed ID: 26026602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Claudin-2 as a mediator of leaky gut barrier during intestinal inflammation.
    Luettig J; Rosenthal R; Barmeyer C; Schulzke JD
    Tissue Barriers; 2015; 3(1-2):e977176. PubMed ID: 25838982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dysbiotic events in gut microbiota: impact on human health.
    Schippa S; Conte MP
    Nutrients; 2014 Dec; 6(12):5786-805. PubMed ID: 25514560
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microbial imbalance and intestinal pathologies: connections and contributions.
    Yang Y; Jobin C
    Dis Model Mech; 2014 Oct; 7(10):1131-42. PubMed ID: 25256712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of MYO9B gene polymorphisms with inflammatory bowel disease in Chinese Han population.
    Hu J; Mei Q; Huang J; Hu NZ; Liu XC; Xu JM
    World J Gastroenterol; 2014 Jun; 20(23):7466-72. PubMed ID: 24966617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Central role of the gut epithelial barrier in the pathogenesis of chronic intestinal inflammation: lessons learned from animal models and human genetics.
    Pastorelli L; De Salvo C; Mercado JR; Vecchi M; Pizarro TT
    Front Immunol; 2013 Sep; 4():280. PubMed ID: 24062746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nod2 deficiency is associated with an increased mucosal immunoregulatory response to commensal microorganisms.
    Amendola A; Butera A; Sanchez M; Strober W; Boirivant M
    Mucosal Immunol; 2014 Mar; 7(2):391-404. PubMed ID: 23962873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Introduction to the "paradigm shifts in perspective" series.
    Kaunitz JD
    Dig Dis Sci; 2013 Jul; 58(7):1825-6. PubMed ID: 23756736
    [No Abstract]   [Full Text] [Related]  

  • 40. Intestinal permeability barrier in Crohn's disease: the difficulty in shifting the paradigm.
    Hollander D
    Dig Dis Sci; 2013 Jul; 58(7):1827-9. PubMed ID: 23748679
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.